Electrophysiological evidence of serotonergic impairment in long-term MDMA ("Ecstasy") users

American Journal of Psychiatry

Volumn 158, Issue 10, 2001, Pages 1687-1692

  Croft, R J ^a   Klugman, A ^a   Baldeweg, T ^a   Gruzelier, J H ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; AUDITORY STIMULATION; BRAIN DYSFUNCTION; BRAIN ELECTROPHYSIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL;

ACOUSTIC STIMULATION; ADULT; AUDITORY PERCEPTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTOXICITY SYNDROMES; REGRESSION ANALYSIS; SEROTONIN; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL;

EID: 0034809694     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.10.1687     Document Type: Article

References (37)

1. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners
2. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain
3. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats
4. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ("ecstasy")
5. (+/-)3,4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
6. In vivo detection of short- and long-term MDMA neurotoxicity - A positron emission tomography study in the living baboon brain
7. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
8. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
9. Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users: Preliminary observations
10. Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): A controlled study in humans
11. Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ("Ecstasy") in humans
12. Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users
13. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings
14. Intensity dependence of auditory evoked N1/P2 component and personality
15. Modulatory role of serotonin in neural information processing: Implications of human psychopathology
16. Ecstasy (MDMA) dependence
17. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients
18. Do patients use marijuana as an antidepressant?
19. Auditory-evoked potentials as indicator of brain serotonergic activity - First evidence in behaving cats
20. The relative contributions of ecstasy and cannabis to cognitive impairment
21. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: Effects of tryptophan depletion in healthy subjects
22. Toxic effect of MDMA on brain serotonin neurons
23. Memory deficits associated with recreational use of "ecstasy" (MDMA)
24. Cognitive performance in (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: A controlled study
25. Memory impairment in abstinent MDMA ("Ecstasy") users
26. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: Effects on mood and neuropsychological function?
27. Cognitive performance in recreational users of MDMA of "ecstasy": Evidence for memory deficits
28. Aggression, suicide and serotonin: Relationships to CSF amine metabolites
29. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter
30. Mood and cognitive effects of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): Weekend "high" followed by mid-week low
31. Mood state and brain electric activity in ecstasy users
32. Ecstasy abuse
33. "Ecstasy" (MDMA)-induced panic
34. Chronic paranoid psychosis after misuse of MDMA ("ecstasy")
35. Chronic atypical psychosis associated with MDMA ("ecstasy") abuse
36. Psychiatric illness associated with "ecstasy"